Clinical Study

Adipokines as Possible New Predictors of Cardiovascular Diseases: A Case Control Study

Table 1

Principal characteristics of the sample enrolled are described in the table.

Ischemic heart diseasesCerebrovascular disease
ControlsCasesControlsCases

Number (women %)9 (22.2%)9 (22.2%)9 (22.2%)9 (22.2%)
Age (years) 6 2 . 9 ± 4 . 2 6 3 . 6 ± 4 . 9 6 5 . 5 ± 1 1 . 8 6 5 . 0 ± 1 1 . 7
Waist (cm) 9 8 . 8 ± 6 . 8 9 8 . 6 ± 6 . 7 9 4 . 9 ± 9 . 3 9 3 . 9 ± 9 . 0
BMI (kg/m2) 2 8 . 0 ± 1 . 7 2 8 . 2 ± 2 . 5 2 5 . 1 ± 2 . 4 2 4 . 7 ± 3 . 0
Total colesterol (mmol/L) 5 . 3 9 ± 0 . 8 3 6 . 2 1 ± 0 . 9 5 . 3 8 ± 0 . 8 2 5 . 8 ± 1 . 5 5
HDL colesterol (mmol/L) 1 . 2 6 ± 0 . 3 8 1 . 4 1 ± 0 . 5 1 . 6 5 ± 0 . 6 7 1 . 4 5 ± 0 . 4 3
Triglyceride (mmol/L)1.19 ( 1 ; 2 . 6 7 )1.8 ( 1 . 4 2 ; 3 . 4 2 )1.7 ( 1 . 1 8 ; 2 . 8 8 )1.17 ( 0 . 9 6 ; 1 . 6 4 )
Fasting glycemia (mmol/L) 5 . 5 2 ± 0 . 8 9 5 . 9 9 ± 1 . 6 4 4 . 9 8 ± 0 . 8 5 . 7 7 ± 0 . 9 1
Diabetes mellitus (%)22.222.211.111.1
Hypertension* (%)33.377.866.766.7
High fasting glycemia* (%)11.122.211.111.1
High waist* (%)55.668.766.744.4
Low HDL colesterol*(%)33.322.211.111.1
Hypertriglyceridaemia* (%)44.455.622.233.3

*as defined by NCEP criteria.